Vaccinex (VCNX) Competitors $0.74 -0.01 (-1.33%) As of 04/17/2025 12:36 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VCNX vs. SLXN, BFRI, OMGA, MYNZ, AIM, GNPX, LIPO, AYTU, APLM, and GTBPShould you be buying Vaccinex stock or one of its competitors? The main competitors of Vaccinex include Silexion Therapeutics (SLXN), Biofrontera (BFRI), Omega Therapeutics (OMGA), Mainz Biomed (MYNZ), AIM ImmunoTech (AIM), Genprex (GNPX), Lipella Pharmaceuticals (LIPO), Aytu BioPharma (AYTU), Apollomics (APLM), and GT Biopharma (GTBP). These companies are all part of the "pharmaceutical products" industry. Vaccinex vs. Silexion Therapeutics Biofrontera Omega Therapeutics Mainz Biomed AIM ImmunoTech Genprex Lipella Pharmaceuticals Aytu BioPharma Apollomics GT Biopharma Vaccinex (NASDAQ:VCNX) and Silexion Therapeutics (NASDAQ:SLXN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations, community ranking and profitability. Do insiders and institutionals believe in VCNX or SLXN? 50.1% of Vaccinex shares are held by institutional investors. Comparatively, 10.9% of Silexion Therapeutics shares are held by institutional investors. 51.5% of Vaccinex shares are held by company insiders. Comparatively, 33.0% of Silexion Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is VCNX or SLXN more profitable? Company Net Margins Return on Equity Return on Assets VaccinexN/A N/A -383.58% Silexion Therapeutics N/A N/A -249.43% Which has better valuation & earnings, VCNX or SLXN? Silexion Therapeutics has lower revenue, but higher earnings than Vaccinex. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVaccinex$388K4.96-$20.25M-$48.27-0.02Silexion TherapeuticsN/AN/A$260KN/AN/A Does the media refer more to VCNX or SLXN? In the previous week, Vaccinex's average media sentiment score of 0.00 equaled Silexion Therapeutics'average media sentiment score. Company Overall Sentiment Vaccinex Neutral Silexion Therapeutics Neutral Do analysts prefer VCNX or SLXN? Silexion Therapeutics has a consensus target price of $5.00, indicating a potential upside of 566.67%. Given Silexion Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Silexion Therapeutics is more favorable than Vaccinex.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vaccinex 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Silexion Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community favor VCNX or SLXN? Vaccinex received 121 more outperform votes than Silexion Therapeutics when rated by MarketBeat users. However, 100.00% of users gave Silexion Therapeutics an outperform vote while only 60.00% of users gave Vaccinex an outperform vote. CompanyUnderperformOutperformVaccinexOutperform Votes12360.00% Underperform Votes8240.00% Silexion TherapeuticsOutperform Votes2100.00% Underperform VotesNo Votes Which has more risk & volatility, VCNX or SLXN? Vaccinex has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, Silexion Therapeutics has a beta of 0.06, indicating that its share price is 94% less volatile than the S&P 500. SummarySilexion Therapeutics beats Vaccinex on 6 of the 11 factors compared between the two stocks. Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VCNX vs. The Competition Export to ExcelMetricVaccinexPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.76M$6.44B$5.30B$7.34BDividend YieldN/A3.20%5.45%4.30%P/E Ratio-0.026.8921.8617.80Price / Sales4.96230.51380.6697.70Price / CashN/A65.6738.2634.64Price / Book-0.295.936.453.98Net Income-$20.25M$142.99M$3.22B$247.81M1 Month Performance19.35%-13.56%-9.76%-7.85%1 Year Performance-84.77%-8.89%11.48%1.60% Vaccinex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VCNXVaccinexN/A$0.74-1.3%N/A-84.6%$2.76M$388,000.00-0.0240SLXNSilexion TherapeuticsN/A$0.85+0.8%$5.00+486.8%N/A$7.17MN/A0.00N/AGap DownBFRIBiofrontera2.9871 of 5 stars$0.80-4.6%$7.00+773.9%-49.1%$7.11M$37.32M-0.3570Short Interest ↓Negative NewsGap DownOMGAOmega Therapeutics1.7137 of 5 stars$0.13-21.8%$9.20+7,260.0%-94.8%$6.92M$8.10M-0.09120Gap UpMYNZMainz Biomed1.9113 of 5 stars$3.37+1.2%$14.00+315.4%-91.1%$6.74M$893,991.00-0.0530Gap DownAIMAIM ImmunoTech1.765 of 5 stars$0.09-22.3%$2.75+2,908.8%-80.5%$6.61M$170,000.00-0.1920Gap DownHigh Trading VolumeGNPXGenprex4.4105 of 5 stars$0.26-0.8%$10.00+3,680.7%-89.1%$6.39MN/A0.0020Short Interest ↓Positive NewsLIPOLipella Pharmaceuticals2.16 of 5 stars$2.45+0.4%N/A-57.9%$6.25M$536,357.00-0.584Short Interest ↓Gap DownAYTUAytu BioPharma0.8427 of 5 stars$1.00-3.7%N/A-63.6%$6.17M$77.23M-0.69160Positive NewsGap UpAPLMApollomics1.6963 of 5 stars$5.63-5.4%$200.00+3,452.4%-88.3%$6.12M$1.22M0.0045Positive NewsGap UpGTBPGT Biopharma3.4507 of 5 stars$2.29+2.7%$11.00+380.3%-41.3%$5.81MN/A-0.338Short Interest ↓Positive NewsGap Up Related Companies and Tools Related Companies SLXN Competitors BFRI Competitors OMGA Competitors MYNZ Competitors AIM Competitors GNPX Competitors LIPO Competitors AYTU Competitors APLM Competitors GTBP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VCNX) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VCNX Stock Free VCNX Stock Alerts